Industry News

Reckitt Opens OTC Manufacturing Facility

The Happi International Top 30 company is investing $200 million to establish a state-of-the-art factory in North Carolina that will produce Mucinex.

Author Image

By: Lianna Albrizio

Associate Editor

Reckitt Benckiser Group Plc has acquired a pharmaceutical site in Wilson, NC, that will expand its US manufacturing footprint and allow it to produce Mucinex tablets and liquids to meet increased consumer demand for cold and flu symptom relief in the US. Reckitt is investing $200 million to establish a state-of-the-art Mucinex manufacturing facility in North Carolina. The investment will ensure a more resilient supply chain in its largest market. Located in the vicinity of the “Research Tr...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters

Topics